Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Image-Guided Therapy Posters

  • You have access
    Do we still need to assess for lung shunt in all Y90 Liver treatment’s ?
    Mark Tann, Paul Haste and mitchell rice
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1315;
  • You have access
    Randomized Phase 3 Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]: Study Protocol
    Jeremie Calais, Johannes Czernin, Wolfgang Fendler, David Elashoff and Nicholas Nickols
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1319;
  • You have access
    Imaging and therapeutic efficacy of 64Cu-labeled melanin nanoparticles in A431 tumor-bearing nude mouse models
    Huijun Zhou, Lin Li and Zhen Cheng
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1313;
  • You have access
    SPION-GOx conjugate for imaging guided cancer therapy.
    Lingyi Sun, Jiaqi Zhao, Zubin Ouyang and Dexing Zeng
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1316;
  • You have access
    Predict the residual renal function using preoperative GFR of 99mTc-DTPA dynamic renal images on RCC patients with nephron sparing surgery
    Manni Zheng, Binwei Guo, Bin Huang, Sijin Li and Zhifang Wu
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1320;
  • You have access
    Utilizing FDG-PET/CT to Assess Radiation-induced Cardiotoxicity in Patients with Lung Cancer Based on Tumor Location
    Raheleh Taghvaei, Reza Sirous, Alexandra Dreyfuss, Thomas Werner and Abass Alavi
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1314;
  • You have access
    Exploring the role of 99mTc-Mebrofenin in both pre- and post-radioembolisation evaluation of liver function
    Kathy Willowson, Dale Bailey and Geoff Schembri
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1318;
  • You have access
    Prognostic and predictive role of FDG PET-CT in Non-Hodgkin lymphoma patients treated with chimeric antigen receptor (CAR) T‑cell therapy
    ZHU Yunqi, Hu Yongxian, Wang Jiasheng, Zhao Xin, Chen Donghe, Zhang Yafei and Zhao Kui
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1317;
  • You have access
    Non-Invasive Assessment of Chemokine Receptor 4 Expression in Gastroenteropancreatic Neuroendocrine Tumors - A Tumor Grade Analysis
    Rudolf Werner, Alexander Weich, Takahiro Higuchi, Andreas Schirbel, Michael Lassmann, Theodor Kudlich, Ken Herrmann, Michael Scheurlen, Andreas Buck, Hans Wester and Constantin Lapa
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 1042;
  • You have access
    The Protection of Salivary Glands by Amifostine and Vitamin C in Radioiodine Treatment
    Jiangping Li, Jin Jianhua, Jianzhong Liu, Zhifang Wu and Sijin Li
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 1041;

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire